Tip:
Highlight text to annotate it
X
The fund is intended to try to make 5 – 7% return, so it’s going to take these vaccines…
it’s going to distribute them. And making the vaccine’s not the only thing that matters…
we gotta make sure we take it somewhere, it gets used properly… it’s got roads to
get there, it’s got the license to use in their country. Ahh, the Gate Foundation, ahh,
is going to take the first twenty percent of the loss, and then share, and I think some
other folks here, and then share fifty percent of the rest of the loss, so an investor could
(cut off) hopefully no loss, though. Hopefully no loss. An investor could lose forty percent
of the money... they could make the five to seven. And the point of it is to make it,
it’s like… I’m gonna say, a ten-year fund… and the point of it is to intelligently…
you know the worst thing that happens in philanthropy or capital is the bridge to nowhere. Wasted
money. And so with the investors here, we’re gonna be looking to drugs, the Gates Foundation
intelligence, knowing all the things they know… if this works, you know… maybe one
day you don’t have to make any guarantees, and you can do this over and over and over
and not just with drugs and vaccines. This is just a, is a more impactful way to get
more money in an intelligent way invested in the future of these, ahh, projects.